Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Keytruda bounces back in rivalry with Opdivo

First drug in its class to secure FDA approval as a first-line therapy for malignant melanoma

- PMLiVE

Bayer forms JV with gene editing firm CRISPR

$300m investment to find new therapies for blood disorders, blindness and congenital heart disease

- PMLiVE

Digital health: Breaking barriers in Health by Debashis Bhattacharya and Kamlesh Sheth

Co-founding directors of Aegleio, Kamlesh Sheth and Debashis Bhattacharya, urge us to welcome digital health.

Say Communications

EU flag

Nine positive opinions for new drugs at CHMP meeting

Tagrisso, Zurampic and Portrazza among the latest recommendations

- PMLiVE

GSK plans sirukumab filing in rheumatoid arthritis next year

Says phase III trials showed 'no unexpected safety findings'

- PMLiVE

ViiV agrees $1.5bn deal to acquire BMS’ HIV assets

Includes its entire development pipeline - from discovery to preclinical projects

- PMLiVE

Turing CEO Shkreli arrested by FBI in securities fraud probe

Accused of illegally using stock from biopharma firm Retrophin to pay off debts

Lucid group celebrate their outstanding year in style at The Shard

A fabulous montage from our end of year meeting at The Shard. Celebrating our achievements the Lucid way.

Lucid Group Communications Limited

Gilead Sciences

Gilead steps into breach left by AbbVie as Galapagos’ partner

Deal worth $2bn to help rheumatoid arthritis drug filgotinib make it through to the market

- PMLiVE

The gestalt of communications

Why integrated communications results are superior to the sum of their parts 

- PMLiVE

NHS patients set to be denied Opdivo and Kadcyla

NICE rejects BMS and Roche cancer treatments

Eli Lilly HQ

Lilly’s Lantus ‘follow-on’ approved in the US

Basaglar is first insulin product to be licensed via the FDA's truncated 505(b)(2) pathway

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links